Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IC-8 Apthera IOL New Enrollment Post Approval Study

NCT06060041 is registered in ClinicalTrials.gov with Bausch & Lomb Incorporated as lead sponsor.

NCT NCT06060041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06060041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IC-8 Apthera IOL New Enrollment Post Approval Study
Lead sponsor
Bausch & Lomb Incorporated
Phase
Observational
Overall status
Recruiting
Start date
September 8, 2023
Completion date
September 30, 2027
Enrollment
435 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

cataract, posterior capsule opacification, presbyopia